P
PTC Therapeutics
A science-led, patient-centered biopharmaceutical company focused on discovering, developing and commercializing medicine for patients with rare disease
At a glance
- Status
- Listed
- Listing
- IPO 2013
News
Open roles
PTC Therapeutics in the South Plainfield ecosystem
The PTC Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later21 investors entered at this stage
- HEHealthCap
- LFLongwood Fund
- HBHBM BioVentures
- JAJennison Associates
- HIHBM Healthcare Investments
- NHNovo Holdings
- CGCDIB Capital Group
- RURutgers university
- ACAdage Capital
- CBCredit Suisse First Boston
- DVDelphi Ventures
Cercano Management- MFManulife Financial
- BCBay City Capital
- CECelgene
- CSCredit Suisse
- NTNew Medical Technologies
- TGThe Column Group
- AVAmgen Ventures
- BCBrookside Capital
- CBCDI Bioscience
Source: Dealroom Talent Intelligence.
Alumni founders
Former PTC Therapeutics employees who went on to found companies, sorted by Dealroom signal score.
KTKailera TherapeuticsEst. 2024
Ron RenaudUnited States
Stanisław PikulPolandPatents
118 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See PTC Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

